Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Severe
methylenetetrahydrofolate reductase
(
MTHFR
) deficiency is an inborn error of folate metabolism, and is inherited as an autosomal recessive trait.
MTHFR
is a key enzyme in folate-dependent remethylation of homocysteine, and reduces 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. Patients with this severe enzymatic deficiency are biochemically characterised by homocystinuria and hypomethioninaemia, and may suffer from neurological abnormalities, mental retardation and premature vascular disease. Here we report the molecular basis of severe
MTHFR
deficiency in four unrelated families from Turkish/Greek ancestry. By use of reverse-
transcriptase
(RT)-PCR, subsequently followed by direct sequencing analysis, we were able to identify four novel mutations in the
MTHFR
gene: two missense (983A-->G; 1027T-->G) and two nonsense (1084C-->T; 1711C-->T) mutations. Furthermore, a splice variant containing a premature termination codon, was observed in one patient, probably as a secondary effect of the 1027T-->G missense mutation. The ongoing identification and characterisation of mutations in the
MTHFR
gene will provide further insight into the heterogeneity of the clinical phenotype in severe
MTHFR
deficiency.
...
PMID:Identification of four novel mutations in severe methylenetetrahydrofolate reductase deficiency. 978 Oct 30